Showing results (191-200 of 250) with videos related to

Sort By:
Pageof 25
American Journal of Clinical Oncology|December 1, 1992
Phase II evaluation of iproplatin in patients with advanced gastric and pancreatic cancerK P Hubbard, R Pazdur, J A Ajani, et al.
Cancer|October 15, 1991
A Southwest Oncology Group phase II Trial of recombinant tumor necrosis factor in metastatic breast cancerG T Budd, S Green, L H Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Phase I and pharmacokinetic study of exatecan mesylate (DX-8951f): a novel camptothecin analogM E Royce, P M Hoff, P Dumas, et al.
Investigational New Drugs|February 1, 1991
Evaluation of fludarabine phosphate in malignant melanoma. A Southwest Oncology Group studyJ A Kish, K Kopecky, M K Samson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapyY Sugawara, S J Fisher, K R Zasadny, et al.
Cancer|February 15, 1990
High-dose cisplatin for metastatic soft tissue sarcomaG T Budd, B Metch, S P Balcerzak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemiaP F Bross, J Beitz, G Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagusD H Ilson, J Ajani, K Bhalla, et al.
Cancer Treatment Reports|May 1, 1982
Limited squamous cell carcinoma of the lung: a Southwest Oncology Group randomized study of radiation with or without doxorubicin chemotherapy and with or without levamisole immunotherapyJ E White, T Chen, R Reed, et al.
Cancer|October 15, 1992
Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinomaR Pazdur, J J Ajani, J L Abbruzzese, et al.
Pageof 25